{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,1,15]],"date-time":"2026-01-15T10:31:11Z","timestamp":1768473071756,"version":"3.49.0"},"reference-count":66,"publisher":"Springer Science and Business Media LLC","issue":"4","license":[{"start":{"date-parts":[[2019,7,31]],"date-time":"2019-07-31T00:00:00Z","timestamp":1564531200000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"},{"start":{"date-parts":[[2019,7,31]],"date-time":"2019-07-31T00:00:00Z","timestamp":1564531200000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Cancer Chemother Pharmacol"],"published-print":{"date-parts":[[2019,10]]},"DOI":"10.1007\/s00280-019-03898-z","type":"journal-article","created":{"date-parts":[[2019,7,31]],"date-time":"2019-07-31T08:03:51Z","timestamp":1564560231000},"page":"771-780","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":8,"title":["Identification of pharmacodynamic biomarkers and common molecular mechanisms of response to genotoxic agents in cancer cell lines"],"prefix":"10.1007","volume":"84","author":[{"given":"Dong-Joon","family":"Min","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yingdong","family":"Zhao","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Anne","family":"Monks","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Alida","family":"Palmisano","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Curtis","family":"Hose","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Beverly A.","family":"Teicher","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"James H.","family":"Doroshow","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Richard M.","family":"Simon","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2019,7,31]]},"reference":[{"issue":"2","key":"3898_CR1","doi-asserted-by":"publisher","first-page":"430","DOI":"10.1021\/mp300370t","volume":"10","author":"E Moysan","year":"2013","unstructured":"Moysan E, Bastiat G, Benoit JP (2013) Gemcitabine versus Modified Gemcitabine: a review of several promising chemical modifications. Mol Pharm 10(2):430\u2013444. \n                    https:\/\/doi.org\/10.1021\/mp300370t","journal-title":"Mol Pharm"},{"issue":"3","key":"3898_CR2","doi-asserted-by":"publisher","first-page":"3403","DOI":"10.3390\/ijms15033403","volume":"15","author":"LH Swift","year":"2014","unstructured":"Swift LH, Golsteyn RM (2014) Genotoxic anti-cancer agents and their relationship to DNA damage, mitosis, and checkpoint adaptation in proliferating cancer cells. Int J Mol Sci 15(3):3403\u20133431. \n                    https:\/\/doi.org\/10.3390\/ijms15033403","journal-title":"Int J Mol Sci"},{"issue":"8","key":"3898_CR3","doi-asserted-by":"publisher","first-page":"675","DOI":"10.1002\/emmm.201101131","volume":"4","author":"NA Saunders","year":"2012","unstructured":"Saunders NA, Simpson F, Thompson EW, Hill MM, Endo-Munoz L, Leggatt G, Minchin RF, Guminski A (2012) Role of intratumoural heterogeneity in cancer drug resistance: molecular and clinical perspectives. EMBO Mol Med 4(8):675\u2013684. \n                    https:\/\/doi.org\/10.1002\/emmm.201101131","journal-title":"EMBO Mol Med"},{"issue":"4","key":"3898_CR4","doi-asserted-by":"publisher","first-page":"e178","DOI":"10.1016\/S1470-2045(11)70335-7","volume":"13","author":"NC Turner","year":"2012","unstructured":"Turner NC, Reis-Filho JS (2012) Genetic heterogeneity and cancer drug resistance. Lancet Oncol 13(4):e178\u2013e185. \n                    https:\/\/doi.org\/10.1016\/S1470-2045(11)70335-7","journal-title":"Lancet Oncol"},{"key":"3898_CR5","doi-asserted-by":"publisher","first-page":"91","DOI":"10.1186\/1756-9966-30-91","volume":"30","author":"N Eckstein","year":"2011","unstructured":"Eckstein N (2011) Platinum resistance in breast and ovarian cancer cell lines. J Exp Clin Cancer Res 30:91. \n                    https:\/\/doi.org\/10.1186\/1756-9966-30-91","journal-title":"J Exp Clin Cancer Res"},{"issue":"5","key":"3898_CR6","doi-asserted-by":"publisher","first-page":"648","DOI":"10.1016\/j.chembiol.2013.04.007","volume":"20","author":"K Cheung-Ong","year":"2013","unstructured":"Cheung-Ong K, Giaever G, Nislow C (2013) DNA-damaging agents in cancer chemotherapy: serendipity and chemical biology. Chem Biol 20(5):648\u2013659. \n                    https:\/\/doi.org\/10.1016\/j.chembiol.2013.04.007","journal-title":"Chem Biol"},{"issue":"9","key":"3898_CR7","doi-asserted-by":"publisher","first-page":"587","DOI":"10.1038\/nrc3342","volume":"12","author":"P Bouwman","year":"2012","unstructured":"Bouwman P, Jonkers J (2012) The effects of deregulated DNA damage signalling on cancer chemotherapy response and resistance. Nat Rev Cancer 12(9):587\u2013598. \n                    https:\/\/doi.org\/10.1038\/nrc3342","journal-title":"Nat Rev Cancer"},{"issue":"1","key":"3898_CR8","doi-asserted-by":"publisher","first-page":"e43","DOI":"10.1016\/S1470-2045(14)70380-8","volume":"16","author":"MK Wilson","year":"2015","unstructured":"Wilson MK, Collyar D, Chingos DT, Friedlander M, Ho TW, Karakasis K, Kaye S, Parmar MK, Sydes MR, Tannock IF, Oza AM (2015) Outcomes and endpoints in cancer trials: bridging the divide. Lancet Oncol 16(1):e43\u2013e52. \n                    https:\/\/doi.org\/10.1016\/S1470-2045(14)70380-8","journal-title":"Lancet Oncol"},{"issue":"1","key":"3898_CR9","doi-asserted-by":"publisher","first-page":"e00016","DOI":"10.1002\/psp4.16","volume":"4","author":"DR Mould","year":"2015","unstructured":"Mould DR, Walz AC, Lave T, Gibbs JP, Frame B (2015) Developing exposure\/response models for anticancer drug treatment: special considerations. CPT Pharmacometrics Syst Pharmacol 4(1):e00016. \n                    https:\/\/doi.org\/10.1002\/psp4.16","journal-title":"CPT Pharmacometrics Syst Pharmacol"},{"issue":"2","key":"3898_CR10","doi-asserted-by":"publisher","first-page":"196","DOI":"10.1016\/j.molonc.2012.01.009","volume":"6","author":"J Verweij","year":"2012","unstructured":"Verweij J, de Jonge M, Eskens F, Sleijfer S (2012) Moving molecular targeted drug therapy towards personalized medicine: issues related to clinical trial design. Mol Oncol 6(2):196\u2013203. \n                    https:\/\/doi.org\/10.1016\/j.molonc.2012.01.009","journal-title":"Mol Oncol"},{"issue":"1","key":"3898_CR11","doi-asserted-by":"publisher","first-page":"18","DOI":"10.2214\/AJR.11.6581","volume":"197","author":"V Yaghmai","year":"2011","unstructured":"Yaghmai V, Miller FH, Rezai P, Benson AB 3rd, Salem R (2011) Response to treatment series: part 2, tumor response assessment\u2014using new and conventional criteria. AJR Am J Roentgenol 197(1):18\u201327. \n                    https:\/\/doi.org\/10.2214\/AJR.11.6581","journal-title":"AJR Am J Roentgenol"},{"issue":"6","key":"3898_CR12","first-page":"596","volume":"10","author":"S Mizuarai","year":"2010","unstructured":"Mizuarai S, Irie H, Kotani H (2010) Gene expression-based pharmacodynamic biomarkers: the beginning of a new era in biomarker-driven anti-tumor drug development. Curr Mol Med 10(6):596\u2013607","journal-title":"Curr Mol Med"},{"key":"3898_CR13","doi-asserted-by":"publisher","DOI":"10.1158\/0008-5472.can-18-0989","author":"A Monks","year":"2018","unstructured":"Monks A, Zhao Y, Hose C, Hamed H, Krushkal J, Fang J, Sonkin D, Palmisano A, Polley EC, Fogli LK, Konate MM, Miller SB, Simpson MA, Voth AR, Li MC, Harris E, Wu X, Connelly JW, Rapisarda A, Teicher BA, Simon R, Doroshow JH (2018) The NCI transcriptional pharmacodynamics workbench: a tool to examine dynamic expression profiling of therapeutic response in the NCI-60 cell line panel. Cancer Res. \n                    https:\/\/doi.org\/10.1158\/0008-5472.can-18-0989","journal-title":"Cancer Res"},{"issue":"14","key":"3898_CR14","doi-asserted-by":"publisher","first-page":"3489","DOI":"10.1158\/1078-0432.CCR-16-3083","volume":"23","author":"DR Liston","year":"2017","unstructured":"Liston DR, Davis M (2017) Clinically relevant concentrations of anticancer drugs: a guide for nonclinical studies. Clin Cancer Res 23(14):3489\u20133498. \n                    https:\/\/doi.org\/10.1158\/1078-0432.CCR-16-3083","journal-title":"Clin Cancer Res"},{"issue":"7","key":"3898_CR15","doi-asserted-by":"publisher","first-page":"1878","DOI":"10.1158\/1535-7163.MCT-09-0016","volume":"8","author":"TD Pfister","year":"2009","unstructured":"Pfister TD, Reinhold WC, Agama K, Gupta S, Khin SA, Kinders RJ, Parchment RE, Tomaszewski JE, Doroshow JH, Pommier Y (2009) Topoisomerase I levels in the NCI-60 cancer cell line panel determined by validated ELISA and microarray analysis and correlation with indenoisoquinoline sensitivity. Mol Cancer Ther 8(7):1878\u20131884. \n                    https:\/\/doi.org\/10.1158\/1535-7163.MCT-09-0016","journal-title":"Mol Cancer Ther"},{"issue":"2","key":"3898_CR16","doi-asserted-by":"publisher","first-page":"494","DOI":"10.1002\/jcp.22359","volume":"226","author":"MS Choy","year":"2011","unstructured":"Choy MS, Chen MJ, Manikandan J, Peng ZF, Jenner AM, Melendez AJ, Cheung NS (2011) Up-regulation of endoplasmic reticulum stress-related genes during the early phase of treatment of cultured cortical neurons by the proteasomal inhibitor lactacystin. J Cell Physiol 226(2):494\u2013510. \n                    https:\/\/doi.org\/10.1002\/jcp.22359","journal-title":"J Cell Physiol"},{"key":"3898_CR17","doi-asserted-by":"publisher","first-page":"e02523","DOI":"10.7554\/eLife.02523","volume":"3","author":"SJ Dixon","year":"2014","unstructured":"Dixon SJ, Patel DN, Welsch M, Skouta R, Lee ED, Hayano M, Thomas AG, Gleason CE, Tatonetti NP, Slusher BS, Stockwell BR (2014) Pharmacological inhibition of cystine-glutamate exchange induces endoplasmic reticulum stress and ferroptosis. Elife 3:e02523. \n                    https:\/\/doi.org\/10.7554\/eLife.02523","journal-title":"Elife"},{"issue":"5","key":"3898_CR18","doi-asserted-by":"publisher","first-page":"481","DOI":"10.1038\/ncb2738","volume":"15","author":"J Han","year":"2013","unstructured":"Han J, Back SH, Hur J, Lin YH, Gildersleeve R, Shan J, Yuan CL, Krokowski D, Wang S, Hatzoglou M, Kilberg MS, Sartor MA, Kaufman RJ (2013) ER-stress-induced transcriptional regulation increases protein synthesis leading to cell death. Nat Cell Biol 15(5):481\u2013490. \n                    https:\/\/doi.org\/10.1038\/ncb2738","journal-title":"Nat Cell Biol"},{"issue":"5","key":"3898_CR19","doi-asserted-by":"publisher","first-page":"693","DOI":"10.1128\/mcb.00911-15","volume":"36","author":"CJ Huggins","year":"2015","unstructured":"Huggins CJ, Mayekar MK, Martin N, Saylor KL, Gonit M, Jailwala P, Kasoji M, Haines DC, Quinones OA, Johnson PF (2015) C\/EBPgamma is a critical regulator of cellular stress response networks through heterodimerization with ATF4. Mol Cell Biol 36(5):693\u2013713. \n                    https:\/\/doi.org\/10.1128\/mcb.00911-15","journal-title":"Mol Cell Biol"},{"issue":"3","key":"3898_CR20","doi-asserted-by":"publisher","first-page":"245","DOI":"10.7150\/ijms.8.245","volume":"8","author":"TH Lippert","year":"2011","unstructured":"Lippert TH, Ruoff HJ, Volm M (2011) Current status of methods to assess cancer drug resistance. Int J Med Sci 8(3):245\u2013253","journal-title":"Int J Med Sci"},{"issue":"4","key":"3898_CR21","doi-asserted-by":"publisher","first-page":"892","DOI":"10.1016\/j.bbamem.2008.09.016","volume":"1788","author":"MA Deli","year":"2009","unstructured":"Deli MA (2009) Potential use of tight junction modulators to reversibly open membranous barriers and improve drug delivery. Biochim Biophys Acta 1788(4):892\u2013910. \n                    https:\/\/doi.org\/10.1016\/j.bbamem.2008.09.016","journal-title":"Biochim Biophys Acta"},{"issue":"6","key":"3898_CR22","doi-asserted-by":"publisher","first-page":"e99269","DOI":"10.1371\/journal.pone.0099269","volume":"9","author":"KW Kohn","year":"2014","unstructured":"Kohn KW, Zeeberg BM, Reinhold WC, Pommier Y (2014) Gene expression correlations in human cancer cell lines define molecular interaction networks for epithelial phenotype. PLoS One 9(6):e99269. \n                    https:\/\/doi.org\/10.1371\/journal.pone.0099269","journal-title":"PLoS One"},{"issue":"6","key":"3898_CR23","doi-asserted-by":"publisher","first-page":"947","DOI":"10.1016\/j.molcel.2015.01.034","volume":"58","author":"P Bai","year":"2015","unstructured":"Bai P (2015) Biology of poly(ADP-Ribose) polymerases: the factotums of cell maintenance. Mol Cell 58(6):947\u2013958. \n                    https:\/\/doi.org\/10.1016\/j.molcel.2015.01.034","journal-title":"Mol Cell"},{"issue":"13","key":"3898_CR24","doi-asserted-by":"publisher","first-page":"10746","DOI":"10.18632\/oncotarget.3628","volume":"6","author":"J Frankum","year":"2015","unstructured":"Frankum J, Moudry P, Brough R, Hodny Z, Ashworth A, Bartek J, Lord CJ (2015) Complementary genetic screens identify the E3 ubiquitin ligase CBLC, as a modifier of PARP inhibitor sensitivity. Oncotarget 6(13):10746\u201310758. \n                    https:\/\/doi.org\/10.18632\/oncotarget.3628","journal-title":"Oncotarget"},{"issue":"3","key":"3898_CR25","doi-asserted-by":"publisher","first-page":"267","DOI":"10.1016\/j.dnarep.2011.11.007","volume":"11","author":"SD Andersen","year":"2012","unstructured":"Andersen SD, Keijzers G, Rampakakis E, Engels K, Luhn P, El-Shemerly M, Nielsen FC, Du Y, May A, Bohr VA, Ferrari S, Zannis-Hadjopoulos M, Fu H, Rasmussen LJ (2012) 14-3-3 checkpoint regulatory proteins interact specifically with DNA repair protein human exonuclease 1 (hEXO1) via a semi-conserved motif. DNA Repair (Amst) 11(3):267\u2013277. \n                    https:\/\/doi.org\/10.1016\/j.dnarep.2011.11.007","journal-title":"DNA Repair (Amst)"},{"issue":"5","key":"3898_CR26","doi-asserted-by":"publisher","first-page":"F758","DOI":"10.1152\/ajprenal.2000.278.5.F758","volume":"278","author":"E Bergin","year":"2000","unstructured":"Bergin E, Levine JS, Koh JS, Lieberthal W (2000) Mouse proximal tubular cell-cell adhesion inhibits apoptosis by a cadherin-dependent mechanism. Am J Physiol Renal Physiol 278(5):F758\u2013F768. \n                    https:\/\/doi.org\/10.1152\/ajprenal.2000.278.5.F758","journal-title":"Am J Physiol Renal Physiol"},{"issue":"12","key":"3898_CR27","doi-asserted-by":"publisher","first-page":"2736","DOI":"10.1016\/j.biocel.2013.09.008","volume":"45","author":"J Ni","year":"2013","unstructured":"Ni J, Cozzi P, Hao J, Beretov J, Chang L, Duan W, Shigdar S, Delprado W, Graham P, Bucci J, Kearsley J, Li Y (2013) Epithelial cell adhesion molecule (EpCAM) is associated with prostate cancer metastasis and chemo\/radioresistance via the PI3K\/Akt\/mTOR signaling pathway. Int J Biochem Cell Biol 45(12):2736\u20132748. \n                    https:\/\/doi.org\/10.1016\/j.biocel.2013.09.008","journal-title":"Int J Biochem Cell Biol"},{"issue":"1\u20132","key":"3898_CR28","doi-asserted-by":"publisher","first-page":"207","DOI":"10.1007\/s11010-015-2553-5","volume":"410","author":"G Wang","year":"2015","unstructured":"Wang G, Ma N, Meng L, Wei Y, Gui J (2015) Activation of the phosphatidylinositol 3-kinase\/Akt pathway is involved in lipocalin-2-promoted human pulmonary artery smooth muscle cell proliferation. Mol Cell Biochem 410(1\u20132):207\u2013213. \n                    https:\/\/doi.org\/10.1007\/s11010-015-2553-5","journal-title":"Mol Cell Biochem"},{"issue":"3","key":"3898_CR29","doi-asserted-by":"publisher","first-page":"443","DOI":"10.1097\/MPA.0000000000000460","volume":"45","author":"CC Weng","year":"2016","unstructured":"Weng CC, Kuo KK, Su HT, Hsiao PJ, Chen YW, Wu DC, Hung WC, Cheng KH (2016) Pancreatic tumor progression associated with CD133 overexpression: involvement of increased TERT expression and epidermal growth factor receptor-dependent Akt activation. Pancreas 45(3):443\u2013457. \n                    https:\/\/doi.org\/10.1097\/MPA.0000000000000460","journal-title":"Pancreas"},{"key":"3898_CR30","doi-asserted-by":"publisher","first-page":"6776","DOI":"10.1038\/ncomms7776","volume":"6","author":"GL Zoratti","year":"2015","unstructured":"Zoratti GL, Tanabe LM, Varela FA, Murray AS, Bergum C, Colombo E, Lang JE, Molinolo AA, Leduc R, Marsault E, Boerner J, List K (2015) Targeting matriptase in breast cancer abrogates tumour progression via impairment of stromal-epithelial growth factor signalling. Nat Commun 6:6776. \n                    https:\/\/doi.org\/10.1038\/ncomms7776","journal-title":"Nat Commun"},{"issue":"7","key":"3898_CR31","doi-asserted-by":"publisher","first-page":"466","DOI":"10.1038\/nrc3545","volume":"13","author":"HP Yao","year":"2013","unstructured":"Yao HP, Zhou YQ, Zhang R, Wang MH (2013) MSP-RON signalling in cancer: pathogenesis and therapeutic potential. Nat Rev Cancer 13(7):466\u2013481. \n                    https:\/\/doi.org\/10.1038\/nrc3545","journal-title":"Nat Rev Cancer"},{"issue":"2","key":"3898_CR32","doi-asserted-by":"publisher","first-page":"276","DOI":"10.1158\/1535-7163.MCT-15-0311","volume":"15","author":"HY Chang","year":"2016","unstructured":"Chang HY, Chang TC, Huang WY, Lee CT, Yen CJ, Tsai YS, Tzai TS, Chen SH, Chow NH (2016) RON nuclear translocation under hypoxia potentiates chemoresistance to DNA double-strand break-inducing anticancer drugs. Mol Cancer Ther 15(2):276\u2013286. \n                    https:\/\/doi.org\/10.1158\/1535-7163.MCT-15-0311","journal-title":"Mol Cancer Ther"},{"key":"3898_CR33","doi-asserted-by":"publisher","DOI":"10.1101\/cshperspect.a004184","author":"I Vandecaetsbeek","year":"2011","unstructured":"Vandecaetsbeek I, Vangheluwe P, Raeymaekers L, Wuytack F, Vanoevelen J (2011) The Ca2+ pumps of the endoplasmic reticulum and Golgi apparatus. Cold Spring Harb Perspect Biol. \n                    https:\/\/doi.org\/10.1101\/cshperspect.a004184","journal-title":"Cold Spring Harb Perspect Biol"},{"issue":"2","key":"3898_CR34","doi-asserted-by":"publisher","first-page":"270","DOI":"10.1016\/j.ydbio.2009.12.008","volume":"338","author":"F Zhao","year":"2010","unstructured":"Zhao F, Edwards R, Dizon D, Afrasiabi K, Mastroianni JR, Geyfman M, Ouellette AJ, Andersen B, Lipkin SM (2010) Disruption of Paneth and goblet cell homeostasis and increased endoplasmic reticulum stress in Agr2\u2212\/\u2212 mice. Dev Biol 338(2):270\u2013279. \n                    https:\/\/doi.org\/10.1016\/j.ydbio.2009.12.008","journal-title":"Dev Biol"},{"issue":"4","key":"3898_CR35","doi-asserted-by":"publisher","first-page":"1815","DOI":"10.1016\/j.ajpath.2011.06.038","volume":"179","author":"M Kawaguchi","year":"2011","unstructured":"Kawaguchi M, Takeda N, Hoshiko S, Yorita K, Baba T, Sawaguchi A, Nezu Y, Yoshikawa T, Fukushima T, Kataoka H (2011) Membrane-bound serine protease inhibitor HAI-1 is required for maintenance of intestinal epithelial integrity. Am J Pathol 179(4):1815\u20131826. \n                    https:\/\/doi.org\/10.1016\/j.ajpath.2011.06.038","journal-title":"Am J Pathol"},{"issue":"4","key":"3898_CR36","doi-asserted-by":"publisher","first-page":"2466","DOI":"10.3892\/or.2016.4585","volume":"35","author":"R Zhang","year":"2016","unstructured":"Zhang R, Shi H, Ren F, Li X, Zhang M, Feng W, Jia Y (2016) Knockdown of MACC1 expression increases cisplatin sensitivity in cisplatin-resistant epithelial ovarian cancer cells. Oncol Rep 35(4):2466\u20132472. \n                    https:\/\/doi.org\/10.3892\/or.2016.4585","journal-title":"Oncol Rep"},{"issue":"1","key":"3898_CR37","doi-asserted-by":"publisher","first-page":"64","DOI":"10.1016\/j.canlet.2016.08.015","volume":"382","author":"J Pan","year":"2016","unstructured":"Pan J, Li X, Wu W, Xue M, Hou H, Zhai W, Chen W (2016) Long non-coding RNA UCA1 promotes cisplatin\/gemcitabine resistance through CREB modulating miR-196a-5p in bladder cancer cells. Cancer Lett 382(1):64\u201376. \n                    https:\/\/doi.org\/10.1016\/j.canlet.2016.08.015","journal-title":"Cancer Lett"},{"issue":"4","key":"3898_CR38","doi-asserted-by":"publisher","first-page":"370","DOI":"10.1111\/cas.12366","volume":"105","author":"N Hosoya","year":"2014","unstructured":"Hosoya N, Miyagawa K (2014) Targeting DNA damage response in cancer therapy. Cancer Sci 105(4):370\u2013388. \n                    https:\/\/doi.org\/10.1111\/cas.12366","journal-title":"Cancer Sci"},{"issue":"8","key":"3898_CR39","doi-asserted-by":"publisher","first-page":"e373","DOI":"10.1038\/oncsis.2017.72","volume":"6","author":"T Avril","year":"2017","unstructured":"Avril T, Vauleon E, Chevet E (2017) Endoplasmic reticulum stress signaling and chemotherapy resistance in solid cancers. Oncogenesis 6(8):e373. \n                    https:\/\/doi.org\/10.1038\/oncsis.2017.72","journal-title":"Oncogenesis"},{"issue":"6","key":"3898_CR40","doi-asserted-by":"publisher","first-page":"756","DOI":"10.1002\/humu.22556","volume":"35","author":"B Leroy","year":"2014","unstructured":"Leroy B, Girard L, Hollestelle A, Minna JD, Gazdar AF, Soussi T (2014) Analysis of TP53 mutation status in human cancer cell lines: a reassessment. Hum Mutat 35(6):756\u2013765. \n                    https:\/\/doi.org\/10.1002\/humu.22556","journal-title":"Hum Mutat"},{"issue":"2","key":"3898_CR41","first-page":"76","volume":"7","author":"M Rasti","year":"2015","unstructured":"Rasti M, Azimi T (2015) TP53 Binding to BRCA1 and RAD51 in MCF7 and MDA-MB-468 Breast Cancer Cell Lines In vivo and In vitro. Avicenna J Med Biotechnol 7(2):76\u201379","journal-title":"Avicenna J Med Biotechnol"},{"key":"3898_CR42","doi-asserted-by":"publisher","first-page":"107","DOI":"10.1016\/j.dnarep.2015.01.011","volume":"28","author":"FG Sousa","year":"2015","unstructured":"Sousa FG, Matuo R, Tang SW, Rajapakse VN, Luna A, Sander C, Varma S, Simon PH, Doroshow JH, Reinhold WC, Pommier Y (2015) Alterations of DNA repair genes in the NCI-60 cell lines and their predictive value for anticancer drug activity. DNA Repair (Amst) 28:107\u2013115. \n                    https:\/\/doi.org\/10.1016\/j.dnarep.2015.01.011","journal-title":"DNA Repair (Amst)"},{"key":"3898_CR43","doi-asserted-by":"publisher","first-page":"930509","DOI":"10.1155\/2010\/930509","volume":"2010","author":"T Verfaillie","year":"2010","unstructured":"Verfaillie T, Salazar M, Velasco G, Agostinis P (2010) Linking ER stress to autophagy: potential implications for cancer therapy. Int J Cell Biol 2010:930509. \n                    https:\/\/doi.org\/10.1155\/2010\/930509","journal-title":"Int J Cell Biol"},{"issue":"2","key":"3898_CR44","doi-asserted-by":"publisher","first-page":"89","DOI":"10.1038\/nrm3270","volume":"13","author":"C Hetz","year":"2012","unstructured":"Hetz C (2012) The unfolded protein response: controlling cell fate decisions under ER stress and beyond. Nat Rev Mol Cell Biol 13(2):89\u2013102. \n                    https:\/\/doi.org\/10.1038\/nrm3270","journal-title":"Nat Rev Mol Cell Biol"},{"issue":"10","key":"3898_CR45","doi-asserted-by":"publisher","first-page":"731","DOI":"10.1016\/j.tem.2016.06.002","volume":"27","author":"DJ Shapiro","year":"2016","unstructured":"Shapiro DJ, Livezey M, Yu L, Zheng X, Andruska N (2016) Anticipatory UPR activation: a protective pathway and target in cancer. Trends Endocrinol Metab 27(10):731\u2013741. \n                    https:\/\/doi.org\/10.1016\/j.tem.2016.06.002","journal-title":"Trends Endocrinol Metab"},{"issue":"3","key":"3898_CR46","doi-asserted-by":"publisher","first-page":"184","DOI":"10.1038\/ncb0311-184","volume":"13","author":"I Tabas","year":"2011","unstructured":"Tabas I, Ron D (2011) Integrating the mechanisms of apoptosis induced by endoplasmic reticulum stress. Nat Cell Biol 13(3):184\u2013190. \n                    https:\/\/doi.org\/10.1038\/ncb0311-184","journal-title":"Nat Cell Biol"},{"key":"3898_CR47","doi-asserted-by":"publisher","first-page":"3507","DOI":"10.1016\/j.bbamcr.2013.07.024","volume":"12","author":"H Urra","year":"1833","unstructured":"Urra H, Dufey E, Lisbona F, Rojas-Rivera D (1833) Hetz C (2013) When ER stress reaches a dead end. Biochim Biophys Acta 12:3507\u20133517. \n                    https:\/\/doi.org\/10.1016\/j.bbamcr.2013.07.024","journal-title":"Biochim Biophys Acta"},{"issue":"7","key":"3898_CR48","doi-asserted-by":"publisher","first-page":"736","DOI":"10.4161\/cbt.5.7.2969","volume":"5","author":"MJ Mann","year":"2006","unstructured":"Mann MJ, Hendershot LM (2006) UPR activation alters chemosensitivity of tumor cells. Cancer Biol Ther 5(7):736\u2013740","journal-title":"Cancer Biol Ther"},{"issue":"4","key":"3898_CR49","doi-asserted-by":"publisher","first-page":"1249","DOI":"10.1128\/MCB.21.4.1249-1259.2001","volume":"21","author":"KD McCullough","year":"2001","unstructured":"McCullough KD, Martindale JL, Klotz LO, Aw TY, Holbrook NJ (2001) Gadd153 sensitizes cells to endoplasmic reticulum stress by down-regulating Bcl2 and perturbing the cellular redox state. Mol Cell Biol 21(4):1249\u20131259. \n                    https:\/\/doi.org\/10.1128\/MCB.21.4.1249-1259.2001","journal-title":"Mol Cell Biol"},{"issue":"2","key":"3898_CR50","doi-asserted-by":"publisher","first-page":"145","DOI":"10.1007\/s00428-016-1961-6","volume":"469","author":"N Piton","year":"2016","unstructured":"Piton N, Wason J, Colasse E, Cornic M, Lemoine F, Le Pessot F, Marguet F, Sabourin JC (2016) Endoplasmic reticulum stress, unfolded protein response and development of colon adenocarcinoma. Virchows Arch 469(2):145\u2013154. \n                    https:\/\/doi.org\/10.1007\/s00428-016-1961-6","journal-title":"Virchows Arch"},{"issue":"7","key":"3898_CR51","doi-asserted-by":"publisher","first-page":"e102590","DOI":"10.1371\/journal.pone.0102590","volume":"9","author":"J Gao","year":"2014","unstructured":"Gao J, Yan Q, Liu S, Yang X (2014) Knockdown of EpCAM enhances the chemosensitivity of breast cancer cells to 5-fluorouracil by downregulating the antiapoptotic factor Bcl-2. PLoS One 9(7):e102590. \n                    https:\/\/doi.org\/10.1371\/journal.pone.0102590","journal-title":"PLoS One"},{"issue":"28","key":"3898_CR52","doi-asserted-by":"publisher","first-page":"24947","DOI":"10.18632\/oncotarget.4453","volume":"6","author":"MY Liao","year":"2015","unstructured":"Liao MY, Lai JK, Kuo MY, Lu RM, Lin CW, Cheng PC, Liang KH, Wu HC (2015) An anti-EpCAM antibody EpAb2-6 for the treatment of colon cancer. Oncotarget 6(28):24947\u201324968. \n                    https:\/\/doi.org\/10.18632\/oncotarget.4453","journal-title":"Oncotarget"},{"issue":"7579","key":"3898_CR53","doi-asserted-by":"publisher","first-page":"472","DOI":"10.1038\/nature15748","volume":"527","author":"KR Fischer","year":"2015","unstructured":"Fischer KR, Durrans A, Lee S, Sheng J, Li F, Wong ST, Choi H, El Rayes T, Ryu S, Troeger J, Schwabe RF, Vahdat LT, Altorki NK, Mittal V, Gao D (2015) Epithelial-to-mesenchymal transition is not required for lung metastasis but contributes to chemoresistance. Nature 527(7579):472\u2013476. \n                    https:\/\/doi.org\/10.1038\/nature15748","journal-title":"Nature"},{"issue":"7579","key":"3898_CR54","doi-asserted-by":"publisher","first-page":"525","DOI":"10.1038\/nature16064","volume":"527","author":"X Zheng","year":"2015","unstructured":"Zheng X, Carstens JL, Kim J, Scheible M, Kaye J, Sugimoto H, Wu CC, LeBleu VS, Kalluri R (2015) Epithelial-to-mesenchymal transition is dispensable for metastasis but induces chemoresistance in pancreatic cancer. Nature 527(7579):525\u2013530. \n                    https:\/\/doi.org\/10.1038\/nature16064","journal-title":"Nature"},{"issue":"1","key":"3898_CR55","doi-asserted-by":"publisher","first-page":"e87386","DOI":"10.1371\/journal.pone.0087386","volume":"9","author":"E Zeindl-Eberhart","year":"2014","unstructured":"Zeindl-Eberhart E, Brandl L, Liebmann S, Ormanns S, Scheel SK, Brabletz T, Kirchner T, Jung A (2014) Epithelial-mesenchymal transition induces endoplasmic-reticulum-stress response in human colorectal tumor cells. PLoS One 9(1):e87386. \n                    https:\/\/doi.org\/10.1371\/journal.pone.0087386","journal-title":"PLoS One"},{"issue":"9","key":"3898_CR56","doi-asserted-by":"publisher","first-page":"18148","DOI":"10.3390\/ijms140918148","volume":"14","author":"MJ Kwon","year":"2013","unstructured":"Kwon MJ (2013) Emerging roles of claudins in human cancer. Int J Mol Sci 14(9):18148\u201318180. \n                    https:\/\/doi.org\/10.3390\/ijms140918148","journal-title":"Int J Mol Sci"},{"issue":"1","key":"3898_CR57","doi-asserted-by":"publisher","first-page":"65","DOI":"10.1016\/j.yexcr.2017.12.032","volume":"363","author":"CW Luo","year":"2018","unstructured":"Luo CW, Wu CC, Chang SJ, Chang TM, Chen TY, Chai CY, Chang CL, Hou MF, Pan MR (2018) CHD4-mediated loss of E-cadherin determines metastatic ability in triple-negative breast cancer cells. Exp Cell Res 363(1):65\u201372. \n                    https:\/\/doi.org\/10.1016\/j.yexcr.2017.12.032","journal-title":"Exp Cell Res"},{"issue":"16","key":"3898_CR58","doi-asserted-by":"publisher","first-page":"11555","DOI":"10.1074\/jbc.M112.428920","volume":"288","author":"AM Fortier","year":"2013","unstructured":"Fortier AM, Asselin E, Cadrin M (2013) Keratin 8 and 18 loss in epithelial cancer cells increases collective cell migration and cisplatin sensitivity through claudin1 up-regulation. J Biol Chem 288(16):11555\u201311571. \n                    https:\/\/doi.org\/10.1074\/jbc.M112.428920","journal-title":"J Biol Chem"},{"issue":"1\u20132","key":"3898_CR59","doi-asserted-by":"publisher","first-page":"21","DOI":"10.1007\/s11010-016-2818-7","volume":"423","author":"H Jung","year":"2016","unstructured":"Jung H, Kim B, Moon BI, Oh E-S (2016) Cytokeratin 18 is necessary for initiation of TGF-\u03b21-induced epithelial\u2013mesenchymal transition in breast epithelial cells. Mol Cell Biochem 423(1\u20132):21\u201328","journal-title":"Mol Cell Biochem"},{"issue":"1","key":"3898_CR60","doi-asserted-by":"publisher","first-page":"13","DOI":"10.3727\/096504010X12828372551713","volume":"19","author":"S Prislei","year":"2010","unstructured":"Prislei S, Mariani M, Raspaglio G, Mozzetti S, Filippetti F, Ferrandina G, Scambia G, Ferlini C (2010) RON and cisplatin resistance in ovarian cancer cell lines. Oncol Res 19(1):13\u201322","journal-title":"Oncol Res"},{"issue":"3","key":"3898_CR61","doi-asserted-by":"publisher","first-page":"1130","DOI":"10.1158\/0008-5472.CAN-09-0761","volume":"70","author":"J Logan-Collins","year":"2010","unstructured":"Logan-Collins J, Thomas RM, Yu P, Jaquish D, Mose E, French R, Stuart W, McClaine R, Aronow B, Hoffman RM, Waltz SE, Lowy AM (2010) Silencing of RON receptor signaling promotes apoptosis and gemcitabine sensitivity in pancreatic cancers. Cancer Res 70(3):1130\u20131140. \n                    https:\/\/doi.org\/10.1158\/0008-5472.CAN-09-0761","journal-title":"Cancer Res"},{"issue":"9","key":"3898_CR62","doi-asserted-by":"publisher","first-page":"3274","DOI":"10.1158\/1078-0432.CCR-04-2207","volume":"11","author":"A Perathoner","year":"2005","unstructured":"Perathoner A, Pirkebner D, Brandacher G, Spizzo G, Stadlmann S, Obrist P, Margreiter R, Amberger A (2005) 14-3-3sigma expression is an independent prognostic parameter for poor survival in colorectal carcinoma patients. Clin Cancer Res 11(9):3274\u20133279. \n                    https:\/\/doi.org\/10.1158\/1078-0432.CCR-04-2207","journal-title":"Clin Cancer Res"},{"issue":"7","key":"3898_CR63","doi-asserted-by":"publisher","first-page":"1750","DOI":"10.1111\/febs.12737","volume":"281","author":"Y Fan","year":"2014","unstructured":"Fan Y, Shen B, Tan M, Mu X, Qin Y, Zhang F, Liu Y (2014) Long non-coding RNA UCA1 increases chemoresistance of bladder cancer cells by regulating Wnt signaling. FEBS J 281(7):1750\u20131758. \n                    https:\/\/doi.org\/10.1111\/febs.12737","journal-title":"FEBS J"},{"issue":"2","key":"3898_CR64","doi-asserted-by":"publisher","first-page":"196","DOI":"10.1016\/j.bbrc.2010.01.013","volume":"392","author":"T Yamazaki","year":"2010","unstructured":"Yamazaki T, Sasaki N, Nishi M, Takeshima H (2010) Facilitation of DNA damage-induced apoptosis by endoplasmic reticulum protein mitsugumin23. Biochem Biophys Res Commun 392(2):196\u2013200. \n                    https:\/\/doi.org\/10.1016\/j.bbrc.2010.01.013","journal-title":"Biochem Biophys Res Commun"},{"issue":"20","key":"3898_CR65","doi-asserted-by":"publisher","first-page":"3348","DOI":"10.1016\/j.febslet.2013.08.030","volume":"587","author":"T Yamamori","year":"2013","unstructured":"Yamamori T, Meike S, Nagane M, Yasui H, Inanami O (2013) ER stress suppresses DNA double-strand break repair and sensitizes tumor cells to ionizing radiation by stimulating proteasomal degradation of Rad51. FEBS Lett 587(20):3348\u20133353. \n                    https:\/\/doi.org\/10.1016\/j.febslet.2013.08.030","journal-title":"FEBS Lett"},{"key":"3898_CR66","doi-asserted-by":"publisher","first-page":"11","DOI":"10.3389\/fonc.2015.00011","volume":"5","author":"N Dicks","year":"2015","unstructured":"Dicks N, Gutierrez K, Michalak M, Bordignon V, Agellon LB (2015) Endoplasmic reticulum stress, genome damage, and cancer. Front Oncol 5:11. \n                    https:\/\/doi.org\/10.3389\/fonc.2015.00011","journal-title":"Front Oncol"}],"container-title":["Cancer Chemotherapy and Pharmacology"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00280-019-03898-z.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s00280-019-03898-z\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00280-019-03898-z.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2020,7,29]],"date-time":"2020-07-29T23:25:14Z","timestamp":1596065114000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s00280-019-03898-z"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,7,31]]},"references-count":66,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2019,10]]}},"alternative-id":["3898"],"URL":"https:\/\/doi.org\/10.1007\/s00280-019-03898-z","relation":{},"ISSN":["0344-5704","1432-0843"],"issn-type":[{"value":"0344-5704","type":"print"},{"value":"1432-0843","type":"electronic"}],"subject":[],"published":{"date-parts":[[2019,7,31]]},"assertion":[{"value":"8 February 2019","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"17 June 2019","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"31 July 2019","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Compliance with ethical standards"}},{"value":"The authors declare that they have no competing interests","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}},{"value":"This article does not contain any studies with human participants or animals performed by any of the authors.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethical approval"}}]}}